{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T07:03:59Z","timestamp":1789196639568,"version":"build-2803163510"},"reference-count":104,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.jaad.2017.04.1140","type":"journal-article","created":{"date-parts":[[2018,4,17]],"date-time":"2018-04-17T13:45:47Z","timestamp":1523972747000},"page":"851-861","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"title":["Desquamative gingivitis"],"prefix":"10.1016","volume":"78","author":[{"given":"Andrea D.","family":"Maderal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"III","given":"Paul","family":"Lee Salisbury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph L.","family":"Jorizzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2017.04.1140_bib1","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1111\/j.1365-4632.2011.05348.x","article-title":"Clinical features, diagnosis, and treatment of erythema multiforme: a review for the practicing dermatologist","volume":"51","author":"Sokumbi","year":"2012","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2017.04.1140_bib2","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/S0002-9343(70)80064-X","article-title":"Beh\u00e7et's disease. Report of twelve cases with three manifesting as papilledema","volume":"49","author":"Kalbian","year":"1970","journal-title":"Am J Med"},{"key":"10.1016\/j.jaad.2017.04.1140_bib3","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s00403-016-1667-2","article-title":"Oral lichen planus: a literature review and update","volume":"308","author":"Alrashdan","year":"2016","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.jaad.2017.04.1140_bib4","first-page":"477","article-title":"Graft-versus-host disease of the skin and adjacent mucous membranes","volume":"11","author":"Ziemer","year":"2013","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.jaad.2017.04.1140_bib5","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1111\/j.1468-3083.2008.02825.x","article-title":"Pemphigus","volume":"22","author":"Ioannides","year":"2008","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2017.04.1140_bib6","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1001\/archderm.139.2.228","article-title":"Direct immunofluorescence of plucked hair in pemphigus","volume":"139","author":"Schaerer","year":"2003","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2017.04.1140_bib7","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1001\/archderm.138.9.1252","article-title":"Limitations in enzyme-linked immunosorbent assays for antibodies against desmogleins 1 and 3 in patients with pemphigus","volume":"138","author":"Bystryn","year":"2002","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2017.04.1140_bib8","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1046\/j.1365-2133.2002.04838.x","article-title":"Monitoring disease activity in pemphigus with enzyme-linked immunosorbent assay using recombinant desmogleins 1 and 3","volume":"147","author":"Cheng","year":"2002","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2017.04.1140_bib9","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.jaad.2010.02.052","article-title":"Therapeutic ladder for pemphigus vulgaris: emphasis on achieving complete remission","volume":"64","author":"Strowd","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2017.04.1140_bib10","first-page":"193","article-title":"Classification, clinical manifestations, and immunopathological mechanisms of the epithelial variant of paraneoplastic autoimmune multiorgan syndrome: a reappraisal of paraneoplastic pemphigus","volume":"137","author":"Nguyen","year":"2001","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2017.04.1140_bib11","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1067\/mjd.2000.107248","article-title":"Cicatricial pemphigoid","volume":"43","author":"Fleming","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2017.04.1140_bib12","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1001\/archderm.1993.01680250060007","volume":"129","author":"Chan","year":"1993","journal-title":"Arch Dermatol"},{"issue":"6 pt 1","key":"10.1016\/j.jaad.2017.04.1140_bib13","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/0190-9622(91)70152-R","article-title":"Salt-split human skin substrate for the immunofluorescent screening of serum from patients with cicatricial pemphigoid and a new method of immunoprecipitation with IgA antibodies","volume":"24","author":"Sarret","year":"1991","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2017.04.1140_bib14","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1080\/1744666X.2016.1221343","article-title":"Clinical features and diagnosis of epidermolysis bullosa acquisita","volume":"13","author":"Vorobyev","year":"2017","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.jaad.2017.04.1140_bib15","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/j.1365-2133.2011.10346.x","article-title":"The many faces of epidermolysis bullosa acquisita after serration pattern analysis by direct immunofluorescence microscopy","volume":"165","author":"Buijsrogge","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2017.04.1140_bib16","doi-asserted-by":"crossref","first-page":"747506","DOI":"10.1155\/2014\/747506","article-title":"Conservative approach in patients with pemphigus gingival vulgaris: a pilot study of five cases","volume":"2014","author":"Gambino","year":"2014","journal-title":"Int J Dent"},{"key":"10.1016\/j.jaad.2017.04.1140_bib17","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1111\/jop.12093","article-title":"Plaque control improves the painful symptoms of oral lichen planus gingival lesions. A short-term study","volume":"42","author":"Salgado","year":"2013","journal-title":"J Oral Pathol Med"},{"key":"10.1016\/j.jaad.2017.04.1140_bib18","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1001\/archderm.1980.01640320048012","article-title":"Topically applied fluocinonide in an adhesive base in the treatment of oral vesiculoerosive diseases","volume":"116","author":"Lozada","year":"1980","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2017.04.1140_bib19","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1111\/ijd.12925","article-title":"Efficacy of tacrolimus and\u00a0clobetasol in the treatment of oral lichen planus: a systematic review and meta-analysis","volume":"54","author":"Chamani","year":"2015","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2017.04.1140_bib20","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1034\/j.1600-0714.2003.00173.x","article-title":"Systemic and topical corticosteroid treatment of oral lichen planus: a comparative study with long-term follow-up","volume":"32","author":"Carbone","year":"2003","journal-title":"J Oral Pathol Med"},{"issue":"3 pt 1","key":"10.1016\/j.jaad.2017.04.1140_bib21","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.jaad.2004.10.863","article-title":"Complex aphthosis: a large case series with evaluation algorithm and therapeutic ladder from topicals to thalidomide","volume":"52","author":"Letsinger","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2017.04.1140_bib22","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0140-6736(68)92833-X","article-title":"Topical triamcinolone acetonide in recurrent aphthous stomatitis. A clinical trial","volume":"1","author":"Brown","year":"1968","journal-title":"Lancet"},{"issue":"4 suppl 2","key":"10.1016\/j.jaad.2017.04.1140_bib23","first-page":"S40","article-title":"Topical corticosteroids in dental practice","volume":"50","author":"Savaga","year":"2005","journal-title":"Aust Dent J"},{"key":"10.1016\/j.jaad.2017.04.1140_bib24","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1001\/archderm.138.10.1335","article-title":"Treatment of chronic erosive oral lichen planus with low concentrations of topical tacrolimus: an open prospective study","volume":"138","author":"Olivier","year":"2002","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2017.04.1140_bib25","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1756-185X.2010.01531.x","article-title":"Pimecrolimus versus placebo in genital aphthous ulcers of Beh\u00e7et\u2019s disease: a randomized double-blind controlled trial","volume":"13","author":"Chams-Davatchi","year":"2010","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.jaad.2017.04.1140_bib26","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1001\/archderm.1986.01660170064021","article-title":"Topical application of isotretinoin gel improves oral lichen planus. A double-blind study","volume":"122","author":"Giustina","year":"1986","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2017.04.1140_bib27","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1365-2133.1995.tb05024.x","article-title":"A double-blind, placebo-controlled trial of continuous acyclovir therapy in recurrent erythema multiforme","volume":"132","author":"Tatnall","year":"1995","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2017.04.1140_bib28","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/s004310050561","article-title":"Corticosteroid treatment of erythema multiforme major (Stevens-Johnson syndrome) in children","volume":"156","author":"Kakourou","year":"1997","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.jaad.2017.04.1140_bib29","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1111\/j.1365-2133.1991.tb04965.x","article-title":"The treatment of erythema multiforme major with\u00a0systemic corticosteroids","volume":"124","author":"Wright","year":"1991","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2017.04.1140_bib30","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1001\/archderm.1990.01670270129025","article-title":"Cyclosporine therapy for bullous erythema multiforme","volume":"126","author":"Wilkel","year":"1990","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2017.04.1140_bib31","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/j.1365-2133.1981.tb00780.x","article-title":"Azathioprine therapy in the management of persistent erythema multiforme","volume":"105","author":"Jones","year":"1981","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2017.04.1140_bib32","doi-asserted-by":"crossref","DOI":"10.1111\/dth.12449","article-title":"Treatment of antiviral-resistant recurrent erythema multiforme with dapsone","volume":"30","author":"Oak","year":"2017","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.jaad.2017.04.1140_bib33","first-page":"375","article-title":"Dapsone in the treatment of persistent erythema multiforme","volume":"5","author":"Hoffman","year":"2006","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.jaad.2017.04.1140_bib34","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1159\/000018378","article-title":"Dapsone-responsive persistent erythema multiforme","volume":"200","author":"Mahendran","year":"2000","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2017.04.1140_bib35","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1111\/j.1365-2133.1988.tb02583.x","article-title":"Continuous erythema multiforme clearing on dapsone","volume":"118","author":"Duhra","year":"1988","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2017.04.1140_bib36","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1001\/archderm.138.12.1547","article-title":"Recurrent erythema\u00a0multiforme\/Stevens-Johnson syndrome: response to mycophenolate mofetil","volume":"138","author":"Davis","year":"2002","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2017.04.1140_bib37","doi-asserted-by":"crossref","first-page":"123","DOI":"10.2165\/00128071-200809020-00006","article-title":"Persistent erythema multiforme treated with thalidomide","volume":"9","author":"Chen","year":"2008","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.jaad.2017.04.1140_bib38","first-page":"40","article-title":"Thalidomide as elective treatment in persistent erythema multiforme; report of two cases","volume":"2","author":"Conejo-Mir","year":"2003","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.jaad.2017.04.1140_bib39","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/j.1365-2133.1992.tb08415.x","article-title":"Thalidomide for recurrent erythema multiforme","volume":"126","author":"Moisson","year":"1992","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2017.04.1140_bib40","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2340\/0001555562449450","article-title":"Thalidomide treatment of recurrent erythema multiforme","volume":"62","author":"Bahmer","year":"1982","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaad.2017.04.1140_bib41","doi-asserted-by":"crossref","first-page":"E189","DOI":"10.25011\/cim.v33i3.13725","article-title":"Comparison of colchicine versus prednisolone in recurrent aphthous stomatitis: a double-blind randomized clinical trial","volume":"33","author":"Pakfetrat","year":"2010","journal-title":"Clin Invest Med"},{"key":"10.1016\/j.jaad.2017.04.1140_bib42","doi-asserted-by":"crossref","first-page":"542","DOI":"10.3109\/s10165-009-0200-2","article-title":"Colchicine versus placebo in Beh\u00e7et\u2019s disease: randomized, double-blind, controlled crossover trial","volume":"19","author":"Davatchi","year":"2009","journal-title":"Mod Rheumatol"},{"issue":"3 pt 1","key":"10.1016\/j.jaad.2017.04.1140_bib43","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S0190-9622(94)70211-X","article-title":"Prevention of recurrent aphthous stomatitis with colchicine: an open trial","volume":"31","author":"Katz","year":"1994","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2017.04.1140_bib44","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1136\/ard.36.6.491","article-title":"Beh\u00e7et's syndrome in 32 patients in Yorkshire","volume":"36","author":"Chamberlain","year":"1977","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaad.2017.04.1140_bib45","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1346-8138.2002.tb00263.x","article-title":"Dapsone in Beh\u00e7et's disease: a double-blind, placebo-controlled, cross-over study","volume":"29","author":"Sharquie","year":"2002","journal-title":"J Dermatol"},{"key":"10.1016\/j.jaad.2017.04.1140_bib46","doi-asserted-by":"crossref","first-page":"443","DOI":"10.7326\/0003-4819-128-6-199803150-00004","article-title":"Thalidomide in the treatment of the mucocutaneous lesions of Beh\u00e7et syndrome. A randomized, double-blind, placebo-controlled trial","volume":"128","author":"Hamuryudan","year":"1998","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jaad.2017.04.1140_bib47","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1001\/archderm.1982.01650230003002","article-title":"Thalidomide treatment of recurrent necrotic giant mucocutaneous aphthae and aphthosis","volume":"118","author":"Torras","year":"1982","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2017.04.1140_bib48","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1136\/ard.53.12.828","article-title":"Clinical experience with thalidomide in the management of severe oral and genital ulceration in conditions such as Beh\u00e7et's disease: use of neurophysiological studies to detect thalidomide neuropathy","volume":"53","author":"Gardner-Medwin","year":"1994","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaad.2017.04.1140_bib49","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1001\/archderm.1990.01670310085012","article-title":"Crossover study of thalidomide vs placebo in severe recurrent aphthous stomatitis","volume":"126","author":"Revuz","year":"1990","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2017.04.1140_bib50","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1056\/NEJMoa1408684","article-title":"Apremilast for Beh\u00e7et\u2019s syndrome\u2014a phase 2, placebo-controlled study","volume":"372","author":"Hatemi","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2017.04.1140_bib51","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1365-2133.1982.tb00904.x","article-title":"Severe oral lichen planus: treatment with an aromatic retinoid (etretinate)","volume":"106","author":"Hersle","year":"1982","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2017.04.1140_bib52","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/0190-9622(91)70067-C","article-title":"Treatment of lichen planus with acitretin. A double-blind, placebo-controlled study in 65 patients","volume":"24","author":"Laurberg","year":"1991","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2017.04.1140_bib53","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/0190-9622(93)70082-5","article-title":"Hydroxychloroquine sulfate (Plaquenil) improves oral lichen planus: an open trial","volume":"28","author":"Eisen","year":"1993","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2017.04.1140_bib54","first-page":"286","article-title":"Treatment of erosive oral lichen plaus with methotrexate","volume":"14","author":"Lajevardi","year":"2016","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.jaad.2017.04.1140_bib55","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1155\/2009\/802075","article-title":"Cyclosporine in the management of esophageal lichen planus","volume":"23","author":"Chaklader","year":"2009","journal-title":"Can J Gastroenterol"},{"key":"10.1016\/j.jaad.2017.04.1140_bib56","doi-asserted-by":"crossref","first-page":"121","DOI":"10.2165\/00128071-200708020-00010","article-title":"Etanercept for the management of oral lichen planus","volume":"8","author":"Yarom","year":"2007","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.jaad.2017.04.1140_bib57","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1111\/j.1365-4632.2006.02949.x","article-title":"Effective treatment of erosive lichen planus with thalidomide and topical tacrolimus","volume":"45","author":"Petropoulou","year":"2006","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2017.04.1140_bib58","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/0002-9378(75)90018-6","article-title":"Significant of timing for the postcoital evaluation of cervical mucus","volume":"121","author":"Tredway","year":"1975","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jaad.2017.04.1140_bib59","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1001\/archderm.143.4.511","article-title":"Oral lichen planus: a case series with emphasis on therapy","volume":"143","author":"Torti","year":"2007","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2017.04.1140_bib60","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1001\/archderm.138.3.370","article-title":"The first international\u00a0consensus on mucous membrane pemphigoid: definition, diagnostic criteria, pathogenic factors, medical treatment, and prognostic indicators","volume":"138","author":"Chan","year":"2002","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2017.04.1140_bib61","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S1079-2104(99)70110-1","article-title":"A retrospective study of the management of oral mucous membrane pemphigoid with dapsone","volume":"88","author":"Ciarrocca","year":"1999","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"10.1016\/j.jaad.2017.04.1140_bib62","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0190-9622(82)70014-3","article-title":"Treatment of cicatricial (benign mucous membrane) pemphigoid with dapsone","volume":"6","author":"Rogers","year":"1982","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2017.04.1140_bib63","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/bjd.12041","article-title":"Oral cyclophosphamide without corticosteroids to treat mucous membrane pemphigoid","volume":"168","author":"Munyangango","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2017.04.1140_bib64","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1097\/ICO.0000000000000168","article-title":"Low-dose pulse intravenous cyclophosphamide for severe ocular cicatricial pemphigoid in elderly patients","volume":"33","author":"Friedman","year":"2014","journal-title":"Cornea"},{"key":"10.1016\/j.jaad.2017.04.1140_bib65","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1097\/ICO.0b013e31826af7b8","article-title":"Treatment of mucous membrane pemphigoid with mycophenolate mofetil","volume":"32","author":"Nottage","year":"2013","journal-title":"Cornea"},{"key":"10.1016\/j.jaad.2017.04.1140_bib66","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.jaad.2016.01.020","article-title":"Rituximab combined with conventional therapy versus conventional therapy alone for the treatment of mucous membrane pemphigoid (MMP)","volume":"74","author":"Maley","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2017.04.1140_bib67","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1001\/archdermatol.2011.54","article-title":"Rituximab for patients with refractory mucous membrane pemphigoid","volume":"147","author":"Le Roux-Villet","year":"2011","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2017.04.1140_bib68","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.ophtha.2009.09.049","article-title":"Combination of rituximab and intravenous immunoglobulin for recalcitrant ocular cicatricial pemphigoid: a preliminary report","volume":"117","author":"Foster","year":"2010","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jaad.2017.04.1140_bib69","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.clim.2003.11.002","article-title":"A nonrandomized comparison of the clinical outcome of ocular involvement in patients with mucous membrane (cicatricial) pemphigoid between conventional immunosuppressive and intravenous immunoglobulin therapies","volume":"111","author":"Letko","year":"2004","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jaad.2017.04.1140_bib70","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1006\/clim.2001.5150","article-title":"Intravenous immunoglobulin therapy in patients with multiple mucosal involvement in mucous membrane pemphigoid","volume":"102","author":"Sami","year":"2002","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jaad.2017.04.1140_bib71","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1001\/archderm.137.9.1181","article-title":"Comparison between intravenous immunoglobulin and conventional immunosuppressive therapy regimens in patients with severe oral pemphigoid: effects on disease progression in patients nonresponsive to dapsone therapy","volume":"137","author":"Ahmed","year":"2001","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2017.04.1140_bib72","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1001\/archderm.1984.01650430127024","article-title":"Adjuvant therapy of pemphigus","volume":"120","author":"Bystryn","year":"1984","journal-title":"Arch Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2017.04.1140_bib73","first-page":"CD006263","article-title":"Interventions for pemphigus vulgaris and pemphigus foliaceus","author":"Martin","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jaad.2017.04.1140_bib74","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.jaad.2013.05.016","article-title":"Assessment of the rate of long-term complete remission off therapy in patients with pemphigus treated with different regimens including medium- and high-dose corticosteroids","volume":"69","author":"Almugairen","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2017.04.1140_bib75","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.jaad.2007.05.024","article-title":"Randomized controlled open-label trial of four treatment regimens for pemphigus vulgaris","volume":"57","author":"Chams-Davatchi","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2017.04.1140_bib76","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1001\/archderm.1973.01620240070024","article-title":"Aathioprine and pemphigus vulgaris","volume":"108","author":"Burton","year":"1973","journal-title":"Arch Dermatol"},{"issue":"3 pt 1","key":"10.1016\/j.jaad.2017.04.1140_bib77","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0190-9622(87)70069-3","article-title":"Azathioprine in the treatment of pemphigus vulgaris. A long-term follow-up","volume":"16","author":"Aberer","year":"1987","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2017.04.1140_bib78","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1111\/j.1468-3083.2012.04717.x","article-title":"Randomized double blind trial of prednisolone and azathioprine, vs. prednisolone and placebo, in the treatment of pemphigus vulgaris","volume":"27","author":"Chams-Davatchi","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2017.04.1140_bib79","first-page":"159","article-title":"Treatment of pemphigus vulgaris with mycophenolate mofetil as a steroid-sparing agent","volume":"18","author":"Esmaili","year":"2008","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.jaad.2017.04.1140_bib80","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1001\/archderm.135.1.54","article-title":"Mycophenolate is effective in the treatment\u00a0of pemphigus vulgaris","volume":"135","author":"Enk","year":"1999","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2017.04.1140_bib81","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1038\/jid.2010.91","article-title":"Treating pemphigus vulgaris with prednisone and mycophenolate mofetil: a multicenter, randomized, placebo-controlled trial","volume":"130","author":"Beissert","year":"2010","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2017.04.1140_bib82","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1001\/archderm.142.11.1447","article-title":"A comparison of oral methylprednisolone plus azathioprine or mycophenolate mofetil for the treatment of pemphigus","volume":"142","author":"Beissert","year":"2006","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2017.04.1140_bib83","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/ced.12073","article-title":"Evaluation of cyclophosphamide pulse therapy as an adjuvant to oral corticosteroid in the management of pemphigus vulgaris","volume":"38","author":"Sharma","year":"2013","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaad.2017.04.1140_bib84","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.autrev.2014.12.002","article-title":"A comprehensive analysis of treatment outcomes in patients with pemphigus vulgaris treated with rituximab","volume":"14","author":"Ahmed","year":"2015","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jaad.2017.04.1140_bib85","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1111\/j.1365-4632.2012.5847.x","article-title":"Adjuvant rituximab in the treatment of pemphigus vulgaris: a phase II clinical trial","volume":"52","author":"Balighi","year":"2013","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2017.04.1140_bib86","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1056\/NEJMoa062930","article-title":"Treatment of pemphigus vulgaris with rituximab and intravenous immune globulin","volume":"355","author":"Ahmed","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2017.04.1140_bib87","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1001\/archderm.144.1.25","article-title":"Multicenter randomized, double-blind, placebo-controlled, clinical trial\u00a0of dapsone as a glucocorticoid-sparing agent in maintenance-phase pemphigus vulgaris","volume":"144","author":"Werth","year":"2008","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2017.04.1140_bib88","doi-asserted-by":"crossref","first-page":"90","DOI":"10.3109\/09546634.2013.873763","article-title":"Assessment of the adjuvant effect of tacrolimus in the management of pemphigus vulgaris: a randomized controlled trial","volume":"26","author":"Dastgheib","year":"2015","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.jaad.2017.04.1140_bib89","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1001\/archderm.1988.01670110019004","article-title":"Controlled study of plasma exchange in pemphigus","volume":"124","author":"Guillaume","year":"1988","journal-title":"Arch Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2017.04.1140_bib90","first-page":"CD004056","article-title":"Interventions for mucous membrane pemphigoid and epidermolysis bullosa acquisita","author":"Kirtschig","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jaad.2017.04.1140_bib91","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/S0738-081X(00)00186-3","article-title":"Epidermolysis bullosa acquisita: update and review","volume":"19","author":"Hallel-Halevy","year":"2001","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.jaad.2017.04.1140_bib92","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.4081\/dr.2011.e38","article-title":"Epidermolysis bullosa acquisita: current diagnosis and therapy","volume":"3","author":"Mehren","year":"2011","journal-title":"Dermatol Rep"},{"key":"10.1016\/j.jaad.2017.04.1140_bib93","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1080\/09546634.2016.1179711","article-title":"Long-term results of rituximab-intravenous immunoglobulin combination therapy in patients with epidermolysis bullosa acquisita resistant to conventional therapy","volume":"28","author":"Oktem","year":"2017","journal-title":"J Dermatol Treat"},{"key":"10.1016\/j.jaad.2017.04.1140_bib94","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1001\/archderm.141.10.1285","article-title":"Paraneoplastic pemphigus associated with Castleman tumor: a commonly reported subtype of paraneoplastic pemphigus in China","volume":"141","author":"Wang","year":"2005","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2017.04.1140_bib95","first-page":"269","article-title":"Anti-CD20 monoclonal antibody (rituximab) for refractory erosive stomatitis secondary to CD20(+) follicular lymphoma-associated paraneoplastic pemphigus","volume":"137","author":"Borradori","year":"2001","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2017.04.1140_bib96","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3960\/jslrt.55.83","article-title":"Rituximab monotherapy and rituximab-containing chemotherapy were effective for\u00a0paraneoplastic pemphigus accompanying follicular lymphoma, but not for subsequent bronchiolitis obliterans","volume":"55","author":"Hirano","year":"2015","journal-title":"J Clin Exp Hematop"},{"key":"10.1016\/j.jaad.2017.04.1140_bib97","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/1346-8138.13160","article-title":"Paraneoplastic pemphigus associated with fatal bronchiolitis obliterans and\u00a0intractable mucosal erosions: treatment with cyclosporin\u00a0in addition to steroid, rituximab and intravenous immunoglobulin","volume":"43","author":"Namba","year":"2016","journal-title":"J Dermatol"},{"key":"10.1016\/j.jaad.2017.04.1140_bib98","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1080\/10428190410001733781","article-title":"Follicular non-Hodgkin's lymphoma with refractory paraneoplastic pemphigus: case report with review of novel treatment modalities","volume":"45","author":"Rossum","year":"2004","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.jaad.2017.04.1140_bib99","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1111\/imj.12576","article-title":"Recalcitrant paraneoplastic pemphigus associated with follicular dendritic cell sarcoma: response to prolonged rituximab and ciclosporin therapy","volume":"44","author":"Hwang","year":"2014","journal-title":"Intern Med J"},{"key":"10.1016\/j.jaad.2017.04.1140_bib100","first-page":"105","article-title":"Paraneoplastic pemphigus in two patients with B-cell non-Hodgkin\u2019s lymphoma: significant responses to cyclophosphamide and prednisolone","volume":"63","author":"Hertzberg","year":"2000","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jaad.2017.04.1140_bib101","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1046\/j.1365-2133.2000.03365.x","article-title":"Use of mycophenolate mofetil in the treatment of paraneoplastic pemphigus","volume":"142","author":"Williams","year":"2000","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2017.04.1140_bib102","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1067\/mtc.2003.60","article-title":"Clinical-pathologic conference: cutaneous paraneoplastic pemphigus associated with benign encapsulated thymoma","volume":"125","author":"Hartz","year":"2003","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jaad.2017.04.1140_bib103","doi-asserted-by":"crossref","first-page":"359","DOI":"10.2340\/00015555-1742","article-title":"A typical case of paraneoplastic pemphigus without detection of malignancy: effectiveness of plasma exchange","volume":"94","author":"Kitagawa","year":"2014","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaad.2017.04.1140_bib104","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.bbmt.2005.09.004","article-title":"National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group","volume":"11","author":"Filipovich","year":"2005","journal-title":"Biol Blood Marrow Transpl"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962217318728?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962217318728?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:46:30Z","timestamp":1759272390000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962217318728"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":104,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["S0190962217318728"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2017.04.1140","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Desquamative gingivitis","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2017.04.1140","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S0190-9622(18)30439-0","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}